Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: Its association with clinicopathologic features

Tatsuhiro Shibata, Satomi Uryu, Akiko Kokubu, Fumie Hosoda, Misao Ohki, Tokuki Sakiyama, Yoshihiro Matsuno, Ryosuke Tsuchiya, Yae Kanai, Tadashi Kondo, Issei Imoto, Johji Inazawa, Setsuo Hirohashi

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The array-based comparative genomic hybridization using microarrayed bacterial artificial chromosome clones allows high-resolution analysis of genome-wide copy number changes in tumors. To analyze the genetic alterations of primary lung adenocarcinoma in a high-throughput way, we used laser-capture microdissection of cancer cells and array comparative genomic hybridization focusing on 800 chromosomal loci containing cancer-related genes. We identified a large number of chromosomal numerical alterations, including frequent amplifications on 7p12, 11q13, 12q14-l5, and 17q21, and two homozygous deletions on 9p21 and one on 8p23. Unsupervised hierarchical clustering analysis of multiple alterations revealed three subgroups of lung adenocarcinoma that were characterized by the accumulation of distinct genetic alterations and associated with smoking history and gender. The mutation status of the epidermal growth factor receptor (EGFR) gene was significantly associated with specific genetic alterations and supervised clustering analysis based on EGFR gene mutations elucidated a subgroup including all EGFR gene mutated tumors, which showed significantly shorter disease-free survival. Our results suggest that there exist multiple molecular carcinogenesis pathways in lung adenocarcinoma that may associate with smoking habits and gender, and that genetic cancer profiling will reveal previously uncharacterized genetic heterogeneity of cancer and be beneficial in estimating patient prognosis and discovering novel cancer-related genes including therapeutic targets.

Original languageEnglish
Pages (from-to)6177-6185
Number of pages9
JournalClinical Cancer Research
Volume11
Issue number17
DOIs
Publication statusPublished - 2005 Sep 1
Externally publishedYes

Fingerprint

Comparative Genomic Hybridization
erbB-1 Genes
Neoplasm Genes
Neoplasms
Cluster Analysis
Smoking
Laser Capture Microdissection
Bacterial Artificial Chromosomes
Mutation
Genetic Heterogeneity
Disease-Free Survival
Habits
Carcinogenesis
Clone Cells
History
Adenocarcinoma of lung
Genome

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis : Its association with clinicopathologic features. / Shibata, Tatsuhiro; Uryu, Satomi; Kokubu, Akiko; Hosoda, Fumie; Ohki, Misao; Sakiyama, Tokuki; Matsuno, Yoshihiro; Tsuchiya, Ryosuke; Kanai, Yae; Kondo, Tadashi; Imoto, Issei; Inazawa, Johji; Hirohashi, Setsuo.

In: Clinical Cancer Research, Vol. 11, No. 17, 01.09.2005, p. 6177-6185.

Research output: Contribution to journalArticle

Shibata, T, Uryu, S, Kokubu, A, Hosoda, F, Ohki, M, Sakiyama, T, Matsuno, Y, Tsuchiya, R, Kanai, Y, Kondo, T, Imoto, I, Inazawa, J & Hirohashi, S 2005, 'Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: Its association with clinicopathologic features', Clinical Cancer Research, vol. 11, no. 17, pp. 6177-6185. https://doi.org/10.1158/1078-0432.CCR-05-0293
Shibata, Tatsuhiro ; Uryu, Satomi ; Kokubu, Akiko ; Hosoda, Fumie ; Ohki, Misao ; Sakiyama, Tokuki ; Matsuno, Yoshihiro ; Tsuchiya, Ryosuke ; Kanai, Yae ; Kondo, Tadashi ; Imoto, Issei ; Inazawa, Johji ; Hirohashi, Setsuo. / Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis : Its association with clinicopathologic features. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 17. pp. 6177-6185.
@article{c216e95659b747d18b269bc5d3e829c8,
title = "Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: Its association with clinicopathologic features",
abstract = "The array-based comparative genomic hybridization using microarrayed bacterial artificial chromosome clones allows high-resolution analysis of genome-wide copy number changes in tumors. To analyze the genetic alterations of primary lung adenocarcinoma in a high-throughput way, we used laser-capture microdissection of cancer cells and array comparative genomic hybridization focusing on 800 chromosomal loci containing cancer-related genes. We identified a large number of chromosomal numerical alterations, including frequent amplifications on 7p12, 11q13, 12q14-l5, and 17q21, and two homozygous deletions on 9p21 and one on 8p23. Unsupervised hierarchical clustering analysis of multiple alterations revealed three subgroups of lung adenocarcinoma that were characterized by the accumulation of distinct genetic alterations and associated with smoking history and gender. The mutation status of the epidermal growth factor receptor (EGFR) gene was significantly associated with specific genetic alterations and supervised clustering analysis based on EGFR gene mutations elucidated a subgroup including all EGFR gene mutated tumors, which showed significantly shorter disease-free survival. Our results suggest that there exist multiple molecular carcinogenesis pathways in lung adenocarcinoma that may associate with smoking habits and gender, and that genetic cancer profiling will reveal previously uncharacterized genetic heterogeneity of cancer and be beneficial in estimating patient prognosis and discovering novel cancer-related genes including therapeutic targets.",
author = "Tatsuhiro Shibata and Satomi Uryu and Akiko Kokubu and Fumie Hosoda and Misao Ohki and Tokuki Sakiyama and Yoshihiro Matsuno and Ryosuke Tsuchiya and Yae Kanai and Tadashi Kondo and Issei Imoto and Johji Inazawa and Setsuo Hirohashi",
year = "2005",
month = "9",
day = "1",
doi = "10.1158/1078-0432.CCR-05-0293",
language = "English",
volume = "11",
pages = "6177--6185",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis

T2 - Its association with clinicopathologic features

AU - Shibata, Tatsuhiro

AU - Uryu, Satomi

AU - Kokubu, Akiko

AU - Hosoda, Fumie

AU - Ohki, Misao

AU - Sakiyama, Tokuki

AU - Matsuno, Yoshihiro

AU - Tsuchiya, Ryosuke

AU - Kanai, Yae

AU - Kondo, Tadashi

AU - Imoto, Issei

AU - Inazawa, Johji

AU - Hirohashi, Setsuo

PY - 2005/9/1

Y1 - 2005/9/1

N2 - The array-based comparative genomic hybridization using microarrayed bacterial artificial chromosome clones allows high-resolution analysis of genome-wide copy number changes in tumors. To analyze the genetic alterations of primary lung adenocarcinoma in a high-throughput way, we used laser-capture microdissection of cancer cells and array comparative genomic hybridization focusing on 800 chromosomal loci containing cancer-related genes. We identified a large number of chromosomal numerical alterations, including frequent amplifications on 7p12, 11q13, 12q14-l5, and 17q21, and two homozygous deletions on 9p21 and one on 8p23. Unsupervised hierarchical clustering analysis of multiple alterations revealed three subgroups of lung adenocarcinoma that were characterized by the accumulation of distinct genetic alterations and associated with smoking history and gender. The mutation status of the epidermal growth factor receptor (EGFR) gene was significantly associated with specific genetic alterations and supervised clustering analysis based on EGFR gene mutations elucidated a subgroup including all EGFR gene mutated tumors, which showed significantly shorter disease-free survival. Our results suggest that there exist multiple molecular carcinogenesis pathways in lung adenocarcinoma that may associate with smoking habits and gender, and that genetic cancer profiling will reveal previously uncharacterized genetic heterogeneity of cancer and be beneficial in estimating patient prognosis and discovering novel cancer-related genes including therapeutic targets.

AB - The array-based comparative genomic hybridization using microarrayed bacterial artificial chromosome clones allows high-resolution analysis of genome-wide copy number changes in tumors. To analyze the genetic alterations of primary lung adenocarcinoma in a high-throughput way, we used laser-capture microdissection of cancer cells and array comparative genomic hybridization focusing on 800 chromosomal loci containing cancer-related genes. We identified a large number of chromosomal numerical alterations, including frequent amplifications on 7p12, 11q13, 12q14-l5, and 17q21, and two homozygous deletions on 9p21 and one on 8p23. Unsupervised hierarchical clustering analysis of multiple alterations revealed three subgroups of lung adenocarcinoma that were characterized by the accumulation of distinct genetic alterations and associated with smoking history and gender. The mutation status of the epidermal growth factor receptor (EGFR) gene was significantly associated with specific genetic alterations and supervised clustering analysis based on EGFR gene mutations elucidated a subgroup including all EGFR gene mutated tumors, which showed significantly shorter disease-free survival. Our results suggest that there exist multiple molecular carcinogenesis pathways in lung adenocarcinoma that may associate with smoking habits and gender, and that genetic cancer profiling will reveal previously uncharacterized genetic heterogeneity of cancer and be beneficial in estimating patient prognosis and discovering novel cancer-related genes including therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=24344435084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344435084&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-05-0293

DO - 10.1158/1078-0432.CCR-05-0293

M3 - Article

C2 - 16144918

AN - SCOPUS:24344435084

VL - 11

SP - 6177

EP - 6185

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 17

ER -